baber/WOPTO huggingface dataset:
Patent AU-2565200-A (AU)
Title: Network arrangement for communication
Inventor: RHODES IAN
IPC: H04L29/06
Filed: 2000-02-18
Abstract: A method for secure communication between a first end terminal located in a first secure network and a second end terminal located in a second secure network, said first and second networks being separated by a relatively insecure intermediate network, wherein the method including the steps of: selectively routing a communication from the first end terminal to the second end terminal over said relatively insecure intermediate network by means of one or more network elements triggerable to selectively route said communication; and encrypting said selectively routed communication by means of an encryption engine before it traverses said intermediate network, wherein said one or more network elements and said encryption engine are located substantially within said firs secure network.
Patent AU-2613500-A (AU)
Title: Multistage process for hydrodesulfurizing-hydrogenating distillates using bulk multimetallic catalyst
Inventor: RILEY KENNETH LLOYD
IPC: B01J27/24
Filed: 2000-01-14
Abstract: Hydroprocessing of petroleum and chemical feedstocks using bulk Group VIII/Group VIB catalysts. Preferred catalysts include those comprised of Ni-Mo-W.
Patent AU-2679884-A (AU)
Title: Enzymic composition for cleaning drains
Inventor: JACOBSON JAMES WILLIAM
IPC: C11D3/386
Filed: 1984-04-13
Abstract: A composition for disintegrating hair which comprises a hair-disintegrating amount of a mixture of a proteolytic enzyme and a disulfide reducing agent, and maintained at a pH that enhances hair denaturation, and a method for clearing pipe clogged with a hair-containing deposit are disclosed.
Patent AU-2691197-A (AU)
Title: Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
Inventor: CHWALISZ KRISTOF
IPC: A61K45/00
Filed: 1997-03-11
Abstract: The invention concerns a medicament containing a combination of individual metering units of an oestrogen and individual metering units of a competitive progesterone antagonist for the separate sequential administration thereof, the medicament being used for hormone replacement therapy. The invention further concerns a pack containing these medicaments.
Patent AU-2748500-A (AU)
Title: Hydraulic fluid compositions
Inventor: LEVESQUE PIERRE
IPC: C10M133/44
Filed: 2000-02-01
Abstract: Functional fluids comprising at least one compound selected from the group consisting of a glycol, a glycol ether, an ester, a hydrocarbon, and mixtures thereof and an effective amount of benzotriazole, a derivative thereof such as tolyltriazole or mixtures thereof and 1,2,4-triazole, a derivative thereof or mixtures thereof. The functional fluids exhibit increased resistance to corrosion and reduced sediment formation and are useful as brake fluids.
Patent AU-2793989-A (AU)
Title: Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
Inventor: MCGINITY JAMES WILLIAM
IPC: A61K47/30
Filed: 1988-11-23
Abstract: The invention is a sustained release dosage or delivery form, such as a tablet, pill, granule or the like capable of providing sustained release of a functionally active ingredient and the method for its manufacture. The invention comprises a matrix of a polymer containing functionally active ingredient and an excipient shaped into a form such as a granule, tablet or the like. Preferably the excipient is a microcrystalline cellulose.
Patent AU-2913601-A (AU)
Title: Potassium channel stress-related proteins and methods of use in plants
Inventor: ISHITANI MANABU
IPC: C12N15/87
Filed: 2000-12-22
Abstract: A transgenic plant transformed by a transcription factor stress-related protein (TFSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated TFSRP, and isolated nucleic acid coding TFSRP, and vectors and host cells containing the latter. Further provided are methods of producing transgenic plants expressing TFSRP, methods of increasing expression of other genes of interest using the TFSRP, methods of identifying novel TFSRP, and methods of modifying the expression of TFSRP in plants.
Patent AU-3011195-A (AU)
Title: Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions
IPC: C07K14/81
Filed: 1995-08-17
Abstract: Cation chromatography with solutions at pH less than 6.0 and low ionic strength can be utilized to purify human  alpha -1 proteinase inhibitor ( alpha -1 PI) from biological fluids including plasma and plasma fractions. The cation chromatography takes advantage of the fact that active  alpha -1 PI does not bind to the cation column under these conditions but other proteins, including denatured  alpha -1 PI and albumin, do. The effect is that active  alpha -1 PI flows through the chromatography column leaving the contaminating proteins behind. Recovery of  alpha -1 PI is high and improvement of purity is dramatic.
Patent AU-3044492-A (AU)
Title: Sustained release thyroactive composition
IPC: A61K31/195
Filed: 1992-12-24
Abstract: Disclosed are sustained release dosage forms of liothyronine, in combination with normal or sustained release of thyroxine in a molar ratio of about 1 to 50 : 1, especially 5 to 20 : 1, useful in thyroid hormone replacement therapy. Surprisingly, it is found that by incorporating liothyronine and optionally thyroxine into a prolonged action dosage form in the described ratios, that the side effects associated with thyroid hormone replacement therapy are greatly reduced or eliminated. The preparation can be a dosage form containing salts of both thyroxine and liothyronine which release in a sustained manner. The preparations will typically contain 5 to 25 mu g of liothryronine. Also disclosed are processes of manufacturing the pharmaceutical preparations. The compositions are useful in treating disease states such as hypothyroidism, hyperthyroidism (in combination with thyrostatic drugs), so-called "TSH" suppressive therapy, and depression.
Patent AU-3201100-A (AU)
Title: Two-stroke internal combustion engine
Inventor: CARLSSON BO
IPC: F02B33/44
Filed: 2000-01-14
Abstract: Crankcase scavenged two-stroke internal combustion engine, in which at least one piston ported air passage, with length Lai, is arranged between an air inlet (2) and each scavenging port (31, 31') of a number of transfer ducts (3, 3'), with length Ls, from the scavenging port to the crankcase. The air passage is arranged from an air inlet (2) equipped with a restriction valve (4), controlled by at least one engine parameter, for instance the carburetor throttle control. The air inlet extends via at least one connecting duct (6, 6') to at least one connecting port (8, 8') in the engine's cylinder wall (12). The connecting port (8, 8') is arranged so that it in connection with piston positions at the top dead center is connected with flow paths (10, 10') embodied in the piston (13), which extend to the upper part of a number of transfer ducts (3, 3'). Each flow path of the piston is arranged so that the air supply is given an essentially equally long period, counted as crank angle or time, as the engine's inlet (22-25), and the length of the inlet into which fuel is added, Li, is greater than 0.6 times the total length of the piston ported air passage Lai and the length of the transfer duct Ls, i.e. 0.6x(Lai+Ls) but smaller than 1.4 times the same length, i.e. 1.4x(Lai+Ls).
Patent AU-3397395-A (AU)
Title: Filter
Inventor: SPREADBURY DAVID JOHN
IPC: H03H21/00
Filed: 1995-09-08
Abstract: PCT No. PCT/GB95/02122 Sec. 371 Date May 28, 1997 Sec. 102(e) Date May 28, 1997 PCT Filed Sep. 8, 1995 PCT Pub. No. WO96/08867 PCT Pub. Date Mar. 21, 1996In adaptive digital filtering, first steps of adapting a filter coefficient dependent on a received data sample, and second steps of filtering by applying an adapted filter coefficient to a received data sample, are alternated so that adapted filter coefficients and modulated data samples are alternatively determined. In consequence, each adapted filter coefficient can be provided for immediate use in filtering.
Patent AU-3742700-A (AU)
Title: Polycarbonate composition useful in optical storage applications
Inventor: GERACE MICHAEL A
IPC: C08K5/1535
Filed: 2000-03-14
Abstract: A thermoplastic polycarbonate composition suitable for the preparation of optical storage devices, for instance optical discs, is disclosed. The composition, containing a stabilizing amount of partially fatty acid ester and as a stabilizer, a compound the structure of which contains at least one benzofuran-2-one group per molecule, features improved resistance to yellowing, reduced haze and high total light transmission values.
Patent AU-3782193-A (AU)
Title: Acylaminoindole derivatives as 5-HT1 agonists
Inventor: MACOR JOHN E
IPC: A61P25/24
Filed: 1993-03-04
Abstract: PCT No. PCT/US93/01807 Sec. 371 Date Sep. 14, 1994 Sec. 102(e) Date Sep. 14, 1994 PCT Filed Mar. 4, 1993 PCT Pub. No. WO93/21180 PCT Pub. Date Oct. 25, 1993.    <IMAGE>  (I)  Compounds of formula (I) where n is 0, 1, or 2; m is 0 or 1; Y and W are each an amino acid residue; R1 is hydrogen, C1-C6 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, aryl, C1-C3 alkylaryl, or C1-C3 alkylheteroaryl, and -(CH2)pR3; R2 is CF3, C1-C6 alkyl, aryl, C1-C3 alkylaryl, and -OR5; R3 is cyano, trifluoromethyl, or -OR4; R4 is hydrogen, C1-C6 alkyl, C1-C3 alkylaryl, or aryl; R5 is C1-C6 alkyl, C1-C3 alkylaryl, or aryl; R6 is hydrogen, -OR7, or -NHCOR7; R7 is hydrogen, C1 to C6 alkyl, aryl or C1 to C3 alkyl-aryl; p is 1, 2, or 3; and the above aryl groups and the aryl moieties of the above alkyl-aryl groups are independently selected from phenyl and substituted phenyl, wherein said substituted phenyl may be substituted with one to three groups selected from C1 to C4 alkyl, halogen, hydroxy, cyano, carboxamide, nitro, and C1 to C4 alkoxy and the pharmaceutically acceptable salts thereof. These compounds are useful in treating migraine and other disorders. These compound are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent AU-3855100-A (AU)
Title: Large scale wdm/tdm sensor array employing erbium-doped fiber amplifiers
Inventor: HODGSON CRAIG W
IPC: G01D5/353
Filed: 2000-01-24
Abstract: An acoustic array includes amplifiers and sensor subarrays, both of which are placed along rungs that connect a return distribution bus with both a signal distribution bus and a pump distribution bus. By placing the amplifiers along the rungs, separate buses can be used for distributing the optical signal and the pump energy for the amplifiers, thereby facilitating the use of standardized couplers. Time division multiplexed sensor subarrays are advantageously connected to unique combinations of laser signal sources and signal return buses, in which the laser signal sources generate different optical wavelengths that are multiplexed on the signal return buses. Optical sources include intensity modulators on either side of an amplifier to eliminate extraneous noise between optical pulses. In addition, amplified spontaneous emission (ASE) filters may be advantageously used to reduce optical noise at wavelengths other than those of interest.
Patent AU-4009585-A (AU)
Title: Nitrification-inhibiting 1-hydroxypyrazole
Inventor: RIEBER NORBERT
IPC: C07D231/12
Filed: 1985-03-14
Abstract: 1-Hydroxypyrazole derivatives of the formula (I)    <IMAGE>  (I) where A is   <IMAGE>  n is 0 or 1, R1, R2 and R3 independently of one another are each hydrogen, chlorine, bromine or iodine, R4 is hydrogen, a straight-chain or branched, open-chain alkyl, alkenyl or alkynyl radical, a cyclic alkyl, alkenyl or alkynyl radical or aryl or aralkyl, and the radicals R4 which are capable of substitution may furthermore be monosubstituted or polysubstituted by halogen, haloalkyl, haloalkoxy, alkyl, alkoxy, alkoxycarbonyl, -OH, =O, -COOH or salts of this, -NO2 or -CN, have a nitrification-inhibiting action. Substances where R4 is not hydrogen when n is 0 are novel.
Patent AU-4021500-A (AU)
Title: Adjustable spinal tether
Inventor: DREWRY TROY D
IPC: A61F2/48
Filed: 2000-03-22
Abstract: An improved apparatus is provided to allow for an adjustable length tether for use in the spine and other parts of the body. The tether comprises an artificial strand with an eyelet formed in one end, the other end being looped through the eyelet. The other end is then secured with respect to the eyelet by a crimp, the excess length being cut off after the length of the tether has been given an appropriate tension. Alternatively, the eyelet end may be formed around a grommet. The crimp may be separate from the grommet or a part of the grommet. The mechanism by which the length is adjusted in some cases will take advantage of the shape memory properties of alloys such as nickel-titanium.
Patent AU-4039399-A (AU)
Title: Sinter-active metal and alloy powders for powder metallurgy applications and methods for their production and their use
Inventor: MENDE BERND
IPC: B22F9/22
Filed: 1999-05-08
Abstract: A process is described for the production of metal powder and alloy powders containing at least one of the metals iron, copper, tin, cobalt or nickel, by mixing aqueous metal salt solutions with an aqueous carboxylic acid solution, separating the precipitation product from the mother liquor and reducing the precipitation product to the metal.
Patent AU-4049101-A (AU)
Title: Device for injecting a fuel into a combustion chamber of an internal combustion engine cylinder
Inventor: ARTIOLI ROMANO
IPC: F02P13/00
Filed: 2000-12-20
Abstract: The invention relates to a device for controlling the injection of a fuel into a combustion chamber (2) of a cylinder of a controlled-ignition or diesel internal combustion engine, the combustion chamber (2) being equipped with at least one spark plug (8).According to the invention, the device comprises:an adapter support (9) intended to be mounted on the cylinder head (3) of the engine, the adapter support being arranged to delimit, on the one hand, at least partially, an injection circuit (7) for the fuel and, on the other hand, a central passage (11) for mounting the spark plug (8),and at least one control injector (I1) for the fuel and one controlled injector (I2) for a rinsing gas, the controlled injectors being mounted outside the combustion chamber, so that their outlets (s1, s2) are connected to the inlet of the injection circuit (7).
Patent AU-4113897-A (AU)
Title: Drosophila melanogaster p70 s6 kinase
Inventor: STEWART MARY
IPC: A01K67/033
Filed: 1997-07-11
Abstract: The invention provides Drosophila melanogasterp70<S6K>, as well as nucleic acids encoding this kinase. The sequence of Drosophila p70<S6K> and the gene encoding it are represented in SEQ ID NO. 2 and 1 respectively. The invention moreover provides mutated forms of Drosophila p70<S6K>, including constitutively active and dominant negative forms thereof, which are useful in the study of p70<S6K> activity. Furthermore, the invention provides expression systems which produce Drosophila p70<S6K> in Drosophila and other organisms, and in particular systems in which expression of Drosophila p70<S6K> has been modulated so as to facilitate the study of its activity.
Patent AU-4419397-A (AU)
Title: Child resistant safety closure
Inventor: QUINTARD DANIEL
IPC: B65D50/04
Filed: 1997-09-17
Abstract: The child resistant safety closure is one that uses a common single start thread on the neck of a container and on a closure. In conjunction with this single start thread there is a single mating projection on the neck and on the closure. These mating projections are in an interference fit until the closure is distorted so that the closure bows outwardly in the region of the projections whereby the projection on the neck and the projection on the closure can pass by one another. The distortion is enhanced by having the plastic of the closure in the area of the projection of a decreased thickness and the neck having flattened portions to provide for a easy distortion of the closure. By the use of a single start common thread and one projection the same closure can be used for containers requiring a safety closure and those not requiring a safety closure. The difference will solely be in the neck finish of the container or on the inner surface of the closure. When the container is to have a safety closure the neck finish has a projection to mate with a projection on the closure. In the instance where the container is not to have a child resistant safety closure either the closure will not have a projection or the neck of the container will not have a projection. In such a case the closure can be freely removed from the container.
Patent AU-4425689-A (AU)
Title: A monitoring device for at least one current pick-up of a transport truck of a rail-borne conveyor
Inventor: PIRCHER HERBERT
IPC: H01R39/58
Filed: 1989-10-30
Abstract: PCT No. PCT/CH89/00186 Sec. 371 Date Jul. 11, 1990 Sec. 102(e) Date Jul. 11, 1990 PCT Filed Oct. 30, 1989 PCT Pub. No. WO90/86607 PCT Pub. Date Jun. 14, 1990.A monitoring device is provided for at least one current pickup of a conveyor truck in a conveyor system running on tracks, whereby when viewed in a direction of travel the current pickup has a profile configuration which changes through wear as the pickup traverses a live rail. The device comprises a receiver for a test signal fixedly mounted on one side of the live rail, a transmitter mounted on the other side of the live rail, a test signal evaluating device that responds to a modified profile configuration of the current pickup resulting from wear, and an alarm signal triggered at a predetermined level of wear of the current pickup.
Patent AU-4519789-A (AU)
Title: Purification of industrial lubricating agents
Inventor: STROM GUNNAR
IPC: C10N30/16
Filed: 1989-11-21
Abstract: Use of polymeric two-phase systems for removing microbial contaminants from industrial lubricating agents, a method of purifying microbial contaminated lubricating agents by mixing the lubricating agent with a polymeric two-phase system, allowing the mixture to separate so as to form a top-phase containing the lubricating agent and a bottom-phase containing at least part of the microbial contaminants, and separating at least a major part of the microbially enriched bottom-phase from the top-phase, a plant for microbial purification of lubricating agents comprising a mixing tank (4) having means (7, 8) for feeding microbially contaminated lubricating agent (S) to the mixing tank, means (13) for feeding a polymeric two-phase system to the mixing tank, a stirrer (5) in the mixing tank, means (9, 10) for feeding the mixture to a separation device (6) for separating the mixture into a top-phase (T) containing lubricating agents, and a bottom-phase (B) containing microbial contaminants, and means (18) for recovering the top-phase of the two-phase system, and a lubricating agent concentrate, in which at least part of the lubricating agent at the same timeforms part of the top-phase component of the polymeric two-phase system.
Patent AU-4588999-A (AU)
Title: Energy storage system
Inventor: HOLTOM STEPHEN WAYNE
IPC: H01T13/60
Filed: 1999-06-09
Abstract: A power control system (10) for managing power output from a battery (11) includes an output terminal (12) for delivering power from the battery (11) to a load, control means (14) connected to the battery (11) to sense pre-selected operating parameters of the battery (11), and in a first mode of operation to provide power from the battery (11) to the output terminals (12). A first capacitor (15), which stores a predetermined quantity of power is connected between the control means (14) and the battery (11), supplies its stored power to the battery (11) in response to a signal from the control means (14) which is in a second mode of operation. A second capacitor (16), which stores a predetermined quantity of power and is connected between control means (14) and the output terminals (12), supplies its stored power to the output terminals (12) in response to a signal from the control means (14) in its second mode of operation.
Patent AU-4628401-A (AU)
Title: Fusible element, method for production thereof, safety circuit and fuse
Inventor: KALTENBORN UWE
IPC: H01H85/06
Filed: 2001-04-17
Abstract: A fuse has a fuse element (6) with a fusible conductor (7) of a conductor material (8) such as Ag, Cu or Al and is provided with doping points (9) following one another at regular intervals. There, the conductor material (8) has a directly adjoining layer of a first compound (10) of the same with a doping material such as In or Ge. It forms mixed crystals which contain the conductor material (8) and the doping material in a fixed stoichiometric ratio, such as for example Ag2In, and is separated from said conductor material by a stable phase boundary. The doping points (9) weaken the fusible conductor by lowering the melting point to below 250° C., so that arc formation rapidly occurs there when there are short-circuit currents, although its electrical resistance per unit of length is under some circumstances only a few percent greater than in the remaining region. The fusible conductor (7) bears a continuous layer of a burn-up material (12). It has an ignition temperature which is preferably lower than the melting point of the first compound (10).
Patent AU-4650097-A (AU)
Title: Chronic fatigue syndrome diagnosis
Inventor: SUHADOLNIK ROBERT J
IPC: C12Q1/34
Filed: 1997-09-19
Abstract: Chronic fatigue syndrome is diagnosed through detection of an about 30 kDa RNase L molecule under native conditions in cellular extracts of RNase L-containing cells such as peripheral blood mononuclear cells. Proteins are fractionated according to molecular weight under nondenaturing conditions. The fractionated proteins are assayed for the presence of the about 30 kDa protein having 2-5A-dependent RNase L enzyme activity. The severity of the affliction may be determined by testing for the presence of RNase L molecules having approximate molecular weights of 30 and 80 kDa. The presence of the about 30 kDa RNase L, and the absence of the about 80 kDa RNase L molecule, correlates with severe chronic fatigue syndrome. The presence of both RNase L molecules indicates a less severe chronic fatigue syndrome affliction. Under denaturing conditions, and in the presence of protease inhibitors, chronic fatigue syndrome may be diagnosed through the detection of an about 37 kDa 2-5A binding protein.
Patent AU-4903496-A (AU)
Title: Production of enzymatically active recombinant carboxypeptidase b
Inventor: HARTMAN JACOB
IPC: C12N9/48
Filed: 1996-01-25
Abstract: The subject invention provides a method of producing enzymatically active CPB which comprises treating a recombinant cell containing DNA encoding ProCPB, so that the DNA directs expression of the ProCPB, recovering from the cell the ProCPB so expressed, treating the recovered ProCPB under conditions permitting folding of the ProCPB, subjecting the folded ProCPB to enzymatic cleavage to produce enzymatically active CPB and purifying the enzymatically active CPB.